{"d":{"__metadata":{"id":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')","uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')","type":"itsystems.Pd.DataServices.DataModel.Business"},"BusinessResponsibilities":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/BusinessResponsibilities"}},"RelatedBusinesses":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/RelatedBusinesses"}},"BusinessRoles":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/BusinessRoles"}},"Publications":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/Publications"}},"LegislativePeriods":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/LegislativePeriods"}},"Sessions":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/Sessions"}},"Preconsultations":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/Preconsultations"}},"Bills":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/Bills"}},"Councils":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/Councils"}},"BusinessTypes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/BusinessTypes"}},"Votes":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/Votes"}},"SubjectsBusiness":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/SubjectsBusiness"}},"BusinessStates":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/BusinessStates"}},"Council":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/Council"}},"Transcripts":{"__deferred":{"uri":"https://ws.parlament.ch/OData.svc/Business(ID=20263603,Language='FR')/Transcripts"}},"ID":20263603,"Language":"FR","BusinessShortNumber":"26.3603","BusinessType":8,"BusinessTypeName":"Interpellation","BusinessTypeAbbreviation":"Ip.","Title":"Politique am\u00e9ricaine en mati\u00e8re de m\u00e9dicaments. Comment r\u00e9agissent les autres pays concern\u00e9s ?","Description":null,"InitialSituation":null,"Proceedings":null,"DraftText":null,"SubmittedText":"<p>L\u2019industrie pharmaceutique suisse estime que les derniers d\u00e9veloppements survenus aux \u00c9tats-Unis exercent sur elle une forte pression et n\u00e9cessitent des mesures d\u2019urgence. Elle vise en particulier les droits de douane grevant les produits pharmaceutiques \u00e9trangers, les nouveaux mod\u00e8les visant \u00e0 faire baisser le prix des m\u00e9dicaments aux \u00c9tats-Unis et les accords pass\u00e9s entre les autorit\u00e9s am\u00e9ricaines et certaines entreprises.</p><p>&nbsp;</p><p>Dans sa r\u00e9ponse \u00e0 l\u2019interpellation Hurni&nbsp;25.4473, le Conseil f\u00e9d\u00e9ral a cependant fait remarquer qu\u2019on ignore encore de nombreux d\u00e9tails concernant ces mod\u00e8les am\u00e9ricains. On ne conna\u00eet en effet ni les modalit\u00e9s concr\u00e8tes de la fixation des prix, ni leurs r\u00e9percussions sur les prix effectifs, ni les pr\u00e9parations concern\u00e9es, ni les cons\u00e9quences indirectes pour l\u2019approvisionnement en Suisse. Le Conseil f\u00e9d\u00e9ral a par ailleurs institu\u00e9 le groupe de travail \u00ab&nbsp;place \u00e9conomique Life Science&nbsp;\u00bb.</p><p>Ces d\u00e9veloppements ne concernent pas que la Suisse. Bien d\u2019autres pays sont confront\u00e9s aux m\u00eames interrogations.</p><p>&nbsp;</p><p>Compte tenu de ces \u00e9l\u00e9ments, je prie le Conseil f\u00e9d\u00e9ral de r\u00e9pondre aux questions qui suivent.</p><ol style=\"list-style-type:decimal;\"><li>Quels pays sont selon lui \u00e9galement concern\u00e9s par les derniers d\u00e9veloppements de la politique am\u00e9ricaine en mati\u00e8re de m\u00e9dicaments&nbsp;?</li><li>Comment y r\u00e9agissent-ils&nbsp;? Ont-ils mis en place des groupes de travail, des accords, des strat\u00e9gies ou des trains de mesures comparables&nbsp;?</li><li>Le Conseil f\u00e9d\u00e9ral se concerte-t-il sur ces questions avec les autres \u00c9tats concern\u00e9s, l\u2019UE ou des organisations internationales&nbsp;? &nbsp;</li><li>Le groupe de travail \u00ab&nbsp;place \u00e9conomique Life Science&nbsp;\u00bb tient-il compte de la r\u00e9action des autres pays aux d\u00e9veloppements constat\u00e9s aux \u00c9tats-Unis&nbsp;?</li><li>Si oui&nbsp;: de quelle mani\u00e8re&nbsp;? Si non&nbsp;: pourquoi&nbsp;?</li><li>Le Conseil f\u00e9d\u00e9ral pr\u00e9voit-il de publier sous une forme appropri\u00e9e ces r\u00e9actions et ces exp\u00e9riences internationales, ou de les mettre \u00e0 la disposition du Parlement&nbsp;?</li></ol><p>&nbsp;</p>","ReasonText":null,"DocumentationText":null,"MotionText":null,"FederalCouncilResponseText":null,"FederalCouncilProposal":null,"FederalCouncilProposalText":null,"FederalCouncilProposalDate":null,"SubmittedBy":"Rechsteiner Thomas","BusinessStatus":202,"BusinessStatusText":"D\u00e9pos\u00e9","BusinessStatusDate":"\/Date(1781049600000)\/","ResponsibleDepartment":4,"ResponsibleDepartmentName":"D\u00e9partement de l'int\u00e9rieur","ResponsibleDepartmentAbbreviation":"DFI","IsLeadingDepartment":true,"Tags":"15|2841","Category":null,"Modified":"\/Date(1783674633547)\/","SubmissionDate":"\/Date(1781049600000)\/","SubmissionCouncil":1,"SubmissionCouncilName":"Conseil national","SubmissionCouncilAbbreviation":"CN","SubmissionSession":5214,"SubmissionLegislativePeriod":52,"FirstCouncil1":1,"FirstCouncil1Name":"Conseil national","FirstCouncil1Abbreviation":"CN","FirstCouncil2":null,"FirstCouncil2Name":null,"FirstCouncil2Abbreviation":null,"TagNames":"\u00c9conomie|Sant\u00e9"}}